Product Images Enalapril Maleate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Enalapril Maleate NDC 50090-6437 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 01
Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 02
This is a table comparing the incidence of various side effects between a group of people who were given Enataprll and another group who were given Placebo. The table lists various side-effects, such as dizziness, chest pain, and urinary tract infections, and the number of individuals in each group who experienced them.*
Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 03
This text provides dosage guidelines for Creatinine based on the patient's renal status measured by clearance in mL/min. Patients with normal renal function should take an initial dose of 5mg/day. Patients with mild impairment have a clearance of < 80 >30 mU/min and should also take an initial dose of 5mg/day. Moderate to severe impairment of <30 mU/min should take an initial dose of 25mg/day. Dialysis patients should take 25mg/day on dialysis days. This medication has a warning for anaphylactoid reactions during membrane exposure. The dosage on nondialysis days should be adjusted depending on the patient's blood pressure response.*
Label Image - lbl500906437
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
